|
Oxaliplatin 130mg/m2 + Capecitabine 1000mg/m2 Clinical Trials
1 actively recruiting trial across 1 location
Also known as: CAPOX
Houston, Texas1 trial
Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER
Baylor College of Medicine
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.